Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANDROFEME application-site pharmacokinetics in postmenopausal women
ACTRN12614000962639Phase 2Completed
- Sponsor
- Lawley Pharmaceuticals
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of testosterone in androgen deficiency, sponsored by Lawley Pharmaceuticals. Primary endpoints: AUC(0-24) of testosterone, Cavg of total and free testosterone and 1 more. Started Feb 2015; status: completed.
02
Drugs
testosterone
03
Conditions
androgen deficiency
Beyond the preview
Go deeper on ACTRN12614000962639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000962639.